Clinical Trials for ADARx Pharmaceuticals

Explore 7 clinical trials worldwide

Showing 1-7 of 7 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: ADARx Pharmaceuticals

Clinical Trials (7)

NCT06990269
Phase 2 Study of ADX-038 in Participants With Geographic Atrophy
PHASE2Not yet recruiting
240 participants
Started: Nov 30, 2025 · Completed: Dec 31, 2027
1 condition1 sponsor0 locations
NCT06960213
STOP-HAE: A Phase 3 Study of ADX-324 in HAE
PHASE3Recruiting
90 participants
Started: Aug 28, 2025 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06989359
Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease
PHASE2Not yet recruiting
30 participants
Started: Jul 31, 2025 · Completed: Jul 31, 2028
3 conditions1 sponsor0 locations
NCT07081503
Phase 1 Study of ADX-626 in Healthy Participants
PHASE1Not yet recruiting
44 participants
Started: Jul 14, 2025 · Completed: Jan 22, 2027
1 condition1 sponsor1 location
NCT06205628
Safety, Tolerability, PK and PD of ADX-850 in Participants With Hypertension
PHASE1Recruiting
120 participants
Started: Mar 21, 2024 · Completed: Sep 30, 2026
2 conditions3 sponsors3 locations
NCT05876312
Safety, Tolerability, PK and PD of ADX-038 in Healthy Participants and Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients
PHASE1/PHASE2Recruiting
50 participants
Started: Aug 7, 2023 · Completed: Sep 30, 2026
1 condition3 sponsors4 locations
NCT05691361
Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients
PHASE1/PHASE2Recruiting
53 participants
Started: Dec 14, 2022 · Completed: Jan 31, 2026
1 condition2 sponsors1 location